Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-04-06 19:07 Tx date 2023-04-04 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+300,000 vol $0.80 each |
1,086,000 | |
Filed 2022-03-21 15:44 Tx date 2022-03-14 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,625
-102,500 vol $1.05 each |
347,500 | |
Filed 2022-03-21 15:42 Tx date 2022-03-14 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,500
-75,000 vol $1.02 each |
450,000 | |
Filed 2022-03-18 15:30 Tx date 2022-03-16 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$182,000
+364,000 vol $0.50 each |
889,000 | |
Filed 2022-03-18 15:29 Tx date 2022-03-16 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-182,000
-364,000 vol $0.50 each |
786,000 | |
Filed 2021-12-08 12:37 Tx date 2021-11-29 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$375,000
+300,000 vol $1.25 each |
1,150,000 | |
Filed 2021-11-04 11:11 Tx date 2021-10-29 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$54,902
+274,510 vol $0.20 each |
1,014,020 | |
Filed 2021-11-04 11:10 Tx date 2021-10-29 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-274,510 vol |
0 | |
Filed 2021-08-31 21:43 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+250,000 vol $0.15 each |
250,000 | |
Filed 2021-08-31 21:42 Tx date 2020-05-13 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+50,000 vol $0.15 each |
300,000 | |
Filed 2021-08-31 21:41 Tx date 2019-11-28 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
||
Filed 2021-08-31 21:33 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-06 13:11 Tx date 2021-07-31 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-25,000 vol |
0 | |
Filed 2020-10-21 19:27 Tx date 2020-10-21 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,850
+15,000 vol $0.19 each |
739,510 | |
Filed 2020-03-18 12:19 Tx date 2017-12-17 |
$XPHY
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
650,000 | ||
Filed 2019-07-11 11:43 Tx date 2017-12-17 |
$XPHY
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-29 17:06 Tx date 2019-11-25 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-193,805 vol |
48,451 | |
Filed 2019-11-29 14:57 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
30 - Acquisition or disposition under a purchase/ownership plan
|
$54,902
+274,510 vol $0.20 each |
274,510 | |
Filed 2019-11-29 14:56 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-29 14:56 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$27,451
+274,510 vol $0.10 each |
724,510 | |
Filed 2019-11-29 13:49 Tx date 2019-11-26 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$45,000
+450,000 vol $0.10 each |
450,000 | |
Filed 2019-11-29 13:48 Tx date 2018-09-17 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-12 17:05 Tx date 2019-08-07 |
$XPHY
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$250,000
+200,000 vol $1.25 each |
265,000 | |
Filed 2019-07-11 11:50 Tx date 2017-12-17 |
$
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
Filed 2019-07-11 11:50 Tx date 2017-12-17 |
$
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
525,000 | ||
Filed 2019-07-11 11:43 Tx date 2017-12-17 |
$
XPhyto Therapeutics Corp. (formerly, CannaBunker Development Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
Filed 2019-02-01 Tx date 2018-09-17 |
$DXD
3D Signatures Inc. |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
242,256 | ||
Filed 2018-10-09 Tx date 2017-09-07 |
$SSH
Seashore Resource Partners Corp. |
Rogers, Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
Filed 2018-10-09 Tx date 2017-09-07 |
$SSH
Seashore Resource Partners Corp. |
Rogers, Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
Filed 2018-09-27 Tx date 2017-09-26 |
$VZLA
Vizsla Resources Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
Filed 2018-08-14 Tx date 2018-07-30 |
$RP
RepliCel Life Sciences Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,500
+50,000 vol $0.43 each |
200,000 | |
Filed 2018-08-14 Tx date 2017-02-03 |
$RP
RepliCel Life Sciences Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$122,999
+75,000 vol $1.64 each |
150,000 | |
Filed 2017-05-25 Tx date 2017-04-26 |
$
Dagobah Ventures Ltd. |
Rogers, Hugh
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-25 Tx date 2017-05-25 |
$
Dagobah Ventures Ltd. |
Rogers, Hugh
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$700.00
+200,000 vol $0.0035 each |
200,000 | |
Filed 2017-02-08 Tx date 2017-02-03 |
$RP
RepliCel Life Sciences Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$122,999
+75,000 vol $1.64 each |
75,000 | |
Filed 2017-02-08 Tx date 2017-02-03 |
$RP
RepliCel Life Sciences Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-03 Tx date 2017-02-03 |
$ZNK
Kootenay Zinc Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
||
Filed 2017-02-03 Tx date 2016-12-28 |
$ZNK
Kootenay Zinc Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
200,000 | |
Filed 2016-12-29 Tx date 2016-12-28 |
$ZNK
Kootenay Zinc Corp. (Formerly Oceanside Capital Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
100,000 | |
Filed 2016-12-29 Tx date 2016-09-07 |
$ZNK
Kootenay Zinc Corp. (Formerly Oceanside Capital Corp.) |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-14 Tx date 2016-12-08 |
$ZNK
Kootenay Zinc Corp. (Formerly Oceanside Capital Corp.) |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$750.00
+25,000 vol $0.03 each |
250,000 | |
Filed 2016-11-16 Tx date 2016-09-07 |
$ZNK
Kootenay Zinc Corp. (Formerly Oceanside Capital Corp.) |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-16 Tx date 2016-11-15 |
$ZNK
Kootenay Zinc Corp. (Formerly Oceanside Capital Corp.) |
Rogers, Hugh
4 - Director of Issuer
Holder: Hugh Rogers Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,750
+225,000 vol $0.03 each |
225,000 |